T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
A.O. Smith
AOS
$8.49B
| $134M | 0.03% |
5,398,300
+9,200
| +0.2% | +$221K |
|
552
ScottsMiracle-Gro
SMG
$3.59B
| $133M | 0.03% |
2,337,422
+5,422
| +0.2% | +$324K |
|
|
WIN
553
DELISTED
Windstream Holdings Inc
WIN
| $133M | 0.03% |
1,698,578
-303,831
| -15% | -$22.1M |
|
|
HIBB
554
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $130M | 0.03% |
2,405,275
-32,880
| -1% | -$1.77M |
|
555
Northern Oil and Gas
NOG
$2.61B
| $130M | 0.03% |
796,117
-13,900
| -2% | -$2.12M |
|
|
DNKN
556
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $130M | 0.03% |
2,830,600
-497,500
| -15% | -$22.8M |
|
557
WEX
WEX
$6.78B
| $130M | 0.03% |
1,235,249
+446,349
| +57% | +$42.6M |
|
558
Acadia Healthcare
ACHC
$2.82B
| $129M | 0.03% |
2,842,770
+689,220
| +32% | +$30.3M |
|
559
Meritage Homes
MTH
$4.8B
| $129M | 0.03% |
6,126,320
-24,820
| -0.4% | -$503K |
|
560
American International
AIG
$39.8B
| $129M | 0.03% |
2,366,424
+49,280
| +2% | +$2.61M |
|
561
Papa John's
PZZA
$804M
| $129M | 0.03% |
3,041,661
+958,739
| +46% | +$42.6M |
|
|
CORE
562
DELISTED
Core Mark Holding Co., Inc.
CORE
| $127M | 0.03% |
5,555,520
+630,000
| +13% | +$12.9M |
|
563
Visteon
VC
$2.86B
| $126M | 0.03% |
1,303,150
-3,550
| -0.3% | -$322K |
|
|
BERY
564
DELISTED
Berry Global Group, Inc.
BERY
| $126M | 0.03% |
5,320,491
+149,298
| +3% | +$3.26M |
|
565
St. Joe Company
JOE
$3.89B
| $125M | 0.03% |
4,925,005
-3,145,171
| -39% | -$67.5M |
|
566
Pebblebrook Hotel Trust
PEB
$2.05B
| $125M | 0.03% |
3,379,137
-566,910
| -14% | -$19.9M |
|
|
CA
567
DELISTED
CA, Inc.
CA
| $125M | 0.03% |
4,340,212
-9,500
| -0.2% | -$281K |
|
|
TMH
568
DELISTED
Team Health Holdings Inc
TMH
| $124M | 0.03% |
2,481,920
-659,830
| -21% | -$31.9M |
|
569
Cognex
CGNX
$10.4B
| $124M | 0.03% |
6,452,892
+105,998
| +2% | +$1.87M |
|
570
Middleby
MIDD
$5.29B
| $124M | 0.03% |
1,497,415
+22,330
| +2% | +$1.84M |
|
|
HMSY
571
DELISTED
HMS Holdings Corp.
HMSY
| $123M | 0.03% |
6,048,589
-4,005,814
| -40% | -$72.2M |
|
572
Assured Guaranty
AGO
$3.35B
| $122M | 0.03% |
4,985,961
-41,230
| -0.8% | -$1.02M |
|
|
ESRX
573
DELISTED
Express Scripts Holding Company
ESRX
| $122M | 0.03% |
1,755,162
-2,576,713
| -59% | -$181M |
|
574
America Movil
AMX
$69.8B
| $122M | 0.03% |
5,857,580
-899,384
| -13% | -$18M |
|
|
LHO
575
DELISTED
LaSalle Hotel Properties
LHO
| $121M | 0.03% |
3,433,460
-532,870
| -13% | -$17.7M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.